Health Bulletins

Experts, Patients and Families to Provide Input on Stem Cell Transplants and Other Complex Malignant Hematology Services

June 30, 2016

Ontario is bringing together clinical experts and people with lived experience to provide input to the government on how to expand capacity and access for stem cell transplants to ensure that patients' needs are being met.

The province has established the Complex Malignant Hematology and Hematopoietic Cell Therapy Consultation Group to provide input on strategies that the province can undertake to improve capacity and patient access for Complex Malignant Hematology and Hematopoietic Cell Therapy. Hematopoietic Cell Therapy, known as stem cell or bone marrow transplants, is a treatment primarily for acute leukemia.

The consultation group will provide input on:

The conveners of the consultation group are:

Due to advances in technology, the province's growing and aging population and increased demand for stem cell therapy as a treatment, the need for CMH and HCT services have increased over time and are expected to continue.

CMH is a complex and evolving area of clinical care that is resource intensive and requires specialized facilities as well as a high degree of specialization for healthcare providers that provide this type of care.

For More Information

If you are a reporter with a question for a story, or with comments about how this News Room section could serve you better, send us an e-mail at: media@moh.gov.on.ca

Media Line
Toll-free: 1-888-414-4774
In Toronto: 416-314-6197

Public Inquiries
Call ServiceOntario, Infoline
at 1-866-532-3161
TTY 1-800-387-5559.
In Toronto, TTY 416-327-4282
Hours of operation : 8:30am - 5:00pm